Effects of 18 months of l-T4 replacement in women with subclinical hypothyroidism

Clinical Endocrinology

Volumn 71, Issue 2, 2009, Pages 298-303

  Adrees, M ^a   Gibney, J ^a   El Saeity, N ^a   Boran, G ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYSTATIN C; EPIDERMAL GROWTH FACTOR RECEPTOR; HOMOCYSTEINE; LEVOTHYROXINE; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ULTRASOUND; VASODILATATION;

ADULT; BLOOD PRESSURE; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HEART; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; KIDNEY; MIDDLE AGED; THYROXINE; TRIGLYCERIDES;

EID: 67650302288     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03509.x     Document Type: Article

References (39)

1. Ridgway, E.C., Ladenson, P.W., Cooper, D.S. et al. (1982) Cardiac function in mild and severe primary hypothyroidism. Life Science, 30, 651 658.
2. Danzi, S. Klein, I. (2003) Thyroid hormone and blood pressure regulation. Current Hypertension Reports, 5, 513 520. (Pubitemid 38898977)
3. Dagre, A.G., Lekakis, J.P., Papaioannou, T.G. et al. (2005) Arterial stiffness is increased in subjects with hypothyroidism. International Journal of Cardiology, 103, 1 6. (Pubitemid 41074596)
4. Duntas, L.H. (2002) Thyroid disease and lipids. Thyroid, 12, 287 293. (Pubitemid 34438931)
5. Pucci, E., Chiovato, L. Pinchera, A. (2000) Thyroid and lipid metabolism. International Journal of Obesity and Related Metabolic Disorders, 24 (Suppl. 2 S109 S112.
6. Jublanc, C. Bruckert, E. (2004) Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters. Seminars in Vascular Medicine, 4, 145 151. (Pubitemid 39433665)
7. Klein, I. Ojamaa, K. (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344, 501 509. (Pubitemid 32164903)
8. Kahaly, G.J. Dillmann, W.H. (2005) Thyroid hormone action in the heart. Endocrine Review, 26, 704 728. (Pubitemid 41127279)
9. Villabona, C., Sahun, M., Roca, M. et al. (1999) Blood Volumes and renal function in overt and subclinical primary hypothyroidism. American Journal of Medical Science, 318, 277 280. (Pubitemid 30349679)
10. Nagasaki, T., Inaba, M., Henmi, Y. et al. (2003) Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clinical Endocrinology, 59, 607 612. (Pubitemid 37357622)
11. Gaspar, I.A. (1968) Postmortem observations on the thyroid in atherosclerosis. Journal of the American Geriatrics Society, 16, 686 695.
12. Steinberg, A.D. (1968) Myxedema and coronary artery disease - a comparative autopsy study. Annals of Internal Medicine, 68, 338 344.
13. Vanhaelst, L., Neve, P. Bastenie, P.A. (1967) Coronary-artery disease in myxoedema. Lancet, 2, 1257 1258.
14. Bagchi, N., Brown, T.R. Parish, R.F. (1990) Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Archives of Internal Medicine, 150, 785 787. (Pubitemid 20122054)
15. Bemben, D.A., Winn, P., Hamm, R.M. et al. (1994) Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. Journal of Family Practice, 38, 577 582. (Pubitemid 24182904)
16. Canaris, G.J., Manowitz, N.R., Mayor, G. et al. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160, 526 534. (Pubitemid 30112276)
17. Hollowell, J.G., Staehling, N.W., Flanders, W.D. et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988-94): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489 499. (Pubitemid 34158210)
18. Lindeman, R.D., Schade, D.S., LaRue, A. et al. (1999) Subclinical hypothyroidism in a biethnic, urban community. Journal of the American Geriatrics Society, 47, 703 709. (Pubitemid 29266638)
19. Parle, J.V., Franklyn, J.A., Cross, K.W. et al. (1991) Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical Endocrinology, 34, 77 83.
20. Sawin, C.T., Chopra, D., Azizi, F. et al. (1979) The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. Journal of the American Medical Association, 242, 247 250. (Pubitemid 9244073)
21. Szabolcs, I., Podoba, J., Feldkamp, J. et al. (1997) Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clinical Endocrinology, 47, 87 92. (Pubitemid 27313993)
22. Tunbridge, W.M., Evered, D.C., Hall, R. et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology, 7, 481 493. (Pubitemid 8235965)
23. Danese, M.D., Ladenson, P.W., Meinert, C.L. et al. (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism, 85, 2993 3001. (Pubitemid 30944493)
24. Monzani, F., Caraccio, N., Kozakowa, M. et al. (2004) Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 89, 2099 2106. (Pubitemid 38619837)
25. Razvi, S., Ingoe, L., Keeka, G. et al. (2007) The beneficial effect of 1-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism, 92, 1715 1723. (Pubitemid 46997177)
26. Coll, E., Botey, A., Alvarez, L. et al. (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. American Journal of Kidney Disease, 36, 29 34. (Pubitemid 30432560)
27. Shlipak, M.G., Katz, R., Sarnak, M.J. et al. (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Annals of Internal Medicine, 145, 237 246. (Pubitemid 46768607)
28. Shlipak, M.G., Sarnak, M.J., Katz, R. et al. (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. New England Journal of Medicine, 352, 2049 2060. (Pubitemid 40664306)
29. Dharnidharka, V.R., Kwon, C. Stevens, G. (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. American Journal of Kidney Diseases, 40, 221 226. (Pubitemid 34827638)
30. Finney, H., Newman, D.J., Gruber, W. et al. (1997) Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clinical Chemistry, 43, 1016 1022. (Pubitemid 27246994)
31. Keevil, B.G., Kilpatrick, E.S., Nichols, S.P. et al. (1998) Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clinical Chemistry, 44, 1535 1539. (Pubitemid 28309116)
32. Bots, M.L., Hoes, A.W., Koudstaal, P.J. et al. (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 96, 1432 1437. (Pubitemid 27375333)
33. Burke, G.L., Evans, G.W., Riley, W.A. et al. (1995) Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Stroke, 26, 386 391.
34. Faber, J., Petersen, L., Wiinberg, N. et al. (2002) Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid, 12, 319 324. (Pubitemid 34438936)
35. Taddei, S., Caraccio, N., Virdis, A. et al. (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism, 88, 3731 3737. (Pubitemid 37034521)
36. den Hollander, J.G., Wulkan, R.W., Mantel, M.J. et al. (2005) Correlation between severity of thyroid dysfunction and renal function. Clinical Endocrinology, 62, 423 427.
37. Montenegro, J., Gonzalez, O., Saracho, R. et al. (1996) Changes in renal function in primary hypothyroidism. American Journal of Kidney Disease, 27, 195 198. (Pubitemid 26055129)
38. Dworkin, L.D. (2001) Serum cystatin C as a marker of glomerular filtration rate. Current Opinion in Nephrology and Hypertension, 10, 551 553. (Pubitemid 32783801)
39. Grubb, A.O. (2000) Cystatin C - properties and use as diagnostic marker. Advances in Clinical Chemistry, 35, 63 99.